The siRNA cocktail targeting interleukin 10 receptor and transforming growth factor-β receptor on dendritic cells potentiates tumour antigen-specific CD8(+) T cell immunity

Dendritic cells (DCs) are promising therapeutic agents in the field of cancer immunotherapy due to their intrinsic immune-priming capacity. The potency of DCs, however, is readily attenuated immediately after their administration in patients as tumours and various immune cells, including DCs, produc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Exp Immunol
Main Authors: Ahn, Y-H, Hong, S-O, Kim, J H, Noh, K H, Song, K-H, Lee, Y-H, Jeon, J-H, Kim, D-W, Seo, J H, Kim, T W
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2015
Assuntos:
Translational
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4469167/
https://ncbi.nlm.nih.gov/pubmed/25753156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12620
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados